The JV fast tracks Strides’ entry into China, the second-largest pharmaceutical market in the World offering a $137 billion (IQVIA) market opportunity.
The Drugs Controller General (India) has granted permission to an Indian firm to conduct Phase-I clinical trial, in pursuance to its application to the DCG(I) on a Zika virus vaccine, the government has said.